Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis-Reference-Cited by-同舟云学术

Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis

Published:2015-04-11 Issue:1 Volume:4 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Hess Georg,Coiffier Bertrand,Crump Michael,Gisselbrecht Christian,Offner Fritz,Romaguera Jorge,Kang Lisa,Moran Pádraig J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s40164-015-0006-1.pdf

Reference17 articles.

1. Chandran R, Gardiner SK, Simon M, Spurgeon SE. Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007. Leuk Lymphoma. 2012;53:1488–93.

2. Dietrich S, Tielesch B, Rieger M, Nickelsen M, Pott C, Witzens-Harig M, et al. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma. Cancer. 2011;117:1901–10.

3. Dreyling M, Kluin-Nelemans HC, Bea S, Klapper W, Vogt N, Delfau-Larue MH, et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European mantle cell lymphoma network. Leuk Lymphoma. 2013;54:699–707.

4. Herrmann A, Hoster E, Zwingers T, Brittinger G, Engelhard M, Meusers P, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009;27:511–8.

5. Argyriou P, Economopoulou P, Papageorgiou S. The role of mTOR inhibitors for the treatment of B-cell lymphomas. Adv Hematol. 2012;2012:435342.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions;Current Research in Pharmacology and Drug Discovery;2021

2. miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR;Experimental Hematology & Oncology;2020-09-26

3. Mantle cell lymphoma;Critical Reviews in Oncology/Hematology;2020-09

4. Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA;Annals of Hematology;2020-06-29

5. Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma;British Journal of Haematology;2017-11-28